Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Analysis of vkorc1 polymorphisms in Norway rats using the roof rat as outgroup.

Díaz JC, Song Y, Moore A, Borchert JN, Kohn MH.

BMC Genet. 2010 May 24;11:43. doi: 10.1186/1471-2156-11-43.

2.

Vkorc1 sequencing suggests anticoagulant resistance in rats in New Zealand.

Cowan PE, Gleeson DM, Howitt RL, Ramón-Laca A, Esther A, Pelz HJ.

Pest Manag Sci. 2017 Jan;73(1):262-266. doi: 10.1002/ps.4304. Epub 2016 May 25.

PMID:
27117082
3.

Evidence of a target resistance to antivitamin K rodenticides in the roof rat Rattus rattus: identification and characterisation of a novel Y25F mutation in the Vkorc1 gene.

Goulois J, Chapuzet A, Lambert V, Chatron N, Tchertanov L, Legros L, Benoît E, Lattard V.

Pest Manag Sci. 2016 Mar;72(3):544-50. doi: 10.1002/ps.4020. Epub 2015 May 26.

PMID:
25847836
4.

Vkorc1 variation in house mice during warfarin and difenacoum field trials.

Endepols S, Klemann N, Song Y, Kohn MH.

Pest Manag Sci. 2013 Mar;69(3):409-13. doi: 10.1002/ps.3306. Epub 2012 Apr 23.

PMID:
22528807
5.

Resistance testing and the effectiveness of difenacoum against Norway rats (Rattus norvegicus) in a tyrosine139cysteine focus of anticoagulant resistance, Westphalia, Germany.

Buckle A, Endepols S, Klemann N, Jacob J.

Pest Manag Sci. 2013 Feb;69(2):233-9. doi: 10.1002/ps.3373. Epub 2012 Dec 4.

PMID:
23208747
6.

Novel mutations in the VKORC1 gene of wild rats and mice--a response to 50 years of selection pressure by warfarin?

Rost S, Pelz HJ, Menzel S, MacNicoll AD, León V, Song KJ, Jäkel T, Oldenburg J, Müller CR.

BMC Genet. 2009 Feb 6;10:4. doi: 10.1186/1471-2156-10-4.

7.

Distribution of VKORC1 single nucleotide polymorphism in wild Rattus norvegicus in France.

Grandemange A, Lasseur R, Longin-Sauvageon C, Benoit E, Berny P.

Pest Manag Sci. 2010 Mar;66(3):270-6. doi: 10.1002/ps.1869.

PMID:
19890940
8.

Prevalence of combinatorial CYP2C9 and VKORC1 genotypes in Puerto Ricans: implications for warfarin management in Hispanics.

Duconge J, Cadilla CL, Windemuth A, Kocherla M, Gorowski K, Seip RL, Bogaard K, Renta JY, Piovanetti P, D'Agostino D, Santiago-Borrero PJ, Ruaño G.

Ethn Dis. 2009 Autumn;19(4):390-5.

9.

Consequences of the Y139F Vkorc1 mutation on resistance to AVKs: in-vivo investigation in a 7th generation of congenic Y139F strain of rats.

Grandemange A, Kohn MH, Lasseur R, Longin-Sauvageon C, Berny P, Benoit E.

Pharmacogenet Genomics. 2009 Oct;19(10):742-50. doi: 10.1097/FPC.0b013e32832ee55b.

10.

The genetic basis of resistance to anticoagulants in rodents.

Pelz HJ, Rost S, Hünerberg M, Fregin A, Heiberg AC, Baert K, MacNicoll AD, Prescott CV, Walker AS, Oldenburg J, Müller CR.

Genetics. 2005 Aug;170(4):1839-47. Epub 2005 May 6.

11.

A vitamin K epoxide reductase-oxidase complex gene polymorphism (-1639G>A) and interindividual variability in the dose-effect of vitamin K antagonists.

Stepien E, Branicka A, Ciesla-Dul M, Undas A.

J Appl Genet. 2009;50(4):399-403. doi: 10.1007/BF03195700.

PMID:
19875892
12.

Brodifacoum is effective against Norway rats (Rattus norvegicus) in a tyrosine139cysteine focus of anticoagulant resistance in Westphalia, Germany.

Buckle AP, Klemann N, Prescott CV.

Pest Manag Sci. 2012 Dec;68(12):1579-85. doi: 10.1002/ps.3352. Epub 2012 Sep 25.

PMID:
23007948
13.

Polymorphism in vkorc1 Gene of Natal Multimammate Mice, Mastomys natalensis, in Tanzania.

Gryseels S, Leirs H, Makundi R, Goüy de Bellocq J.

J Hered. 2015 Sep-Oct;106(5):637-43. doi: 10.1093/jhered/esv054. Epub 2015 Jul 29.

PMID:
26223233
14.

Distribution of rodenticide resistance and zoonotic pathogens in Norway rats in Lower Saxony and Hamburg, Germany.

Runge M, von Keyserlingk M, Braune S, Becker D, Plenge-Bönig A, Freise JF, Pelz HJ, Esther A.

Pest Manag Sci. 2013 Mar;69(3):403-8. doi: 10.1002/ps.3369. Epub 2012 Aug 8.

PMID:
22888034
15.

Warfarin resistance in a French strain of rats.

Lasseur R, Longin-Sauvageon C, Videmann B, Billeret M, Berny P, Benoit E.

J Biochem Mol Toxicol. 2005;19(6):379-85.

PMID:
16421894
16.

VKORC1 and the vitamin K cycle.

Garcia AA, Reitsma PH.

Vitam Horm. 2008;78:23-33. doi: 10.1016/S0083-6729(07)00002-7. Review.

PMID:
18374188
17.

Evaluation of the warfarin-resistance polymorphism, VKORC1 Asp36Tyr, and its effect on dosage algorithms in a genetically heterogeneous anticoagulant clinic.

Shuen AY, Wong BY, Fu L, Selby R, Cole DE.

Clin Biochem. 2012 Apr;45(6):397-401. doi: 10.1016/j.clinbiochem.2012.01.002. Epub 2012 Jan 13.

PMID:
22266406
18.

Rapid single-nucleotide polymorphism detection of cytochrome P450 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genes for the warfarin dose adjustment by the SMart-amplification process version 2.

Aomori T, Yamamoto K, Oguchi-Katayama A, Kawai Y, Ishidao T, Mitani Y, Kogo Y, Lezhava A, Fujita Y, Obayashi K, Nakamura K, Kohnke H, Wadelius M, Ekström L, Skogastierna C, Rane A, Kurabayashi M, Murakami M, Cizdziel PE, Hayashizaki Y, Horiuchi R.

Clin Chem. 2009 Apr;55(4):804-12. doi: 10.1373/clinchem.2008.115295. Epub 2009 Jan 30.

19.

VKORC1 polymorphisms in Brazilians: comparison with the Portuguese and Portuguese-speaking Africans and pharmacogenetic implications.

Suarez-Kurtz G, Amorim A, Damasceno A, Hutz MH, de Moraes MO, Ojopi EB, Pena SD, Perini JA, Prata MJ, Ribeiro-dos-Santos A, Romano-Silva MA, Teixeira D, Struchiner CJ.

Pharmacogenomics. 2010 Sep;11(9):1257-67. doi: 10.2217/pgs.10.89.

PMID:
20860466
20.

Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations.

Wu AH, Wang P, Smith A, Haller C, Drake K, Linder M, Valdes R Jr.

Pharmacogenomics. 2008 Feb;9(2):169-78. doi: 10.2217/14622416.9.2.169.

PMID:
18370846

Supplemental Content

Support Center